The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic ...

AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has ...

AstraZeneca AZN announced that the FDA has accepted the supplemental new drug application (sNDA), seeking approval for the ...

As the nights draw in Bryony Fernandez is preparing for the next phase of helping her fiancé, Jon Ward, to access the ...

A recent report by Patients for Affordable Drugs reveals that pharmaceutical companies have increased prices on more than ...

The fight to lower prescription drug prices is hitting African Americans especially hard. A recent report by Patients ...

NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described as “devastating”.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

NICE and drugmakers AstraZeneca and Daiichi Sankyo have all expressed their disappointment at being unable to agree on a price for Enhertu that would allow it to be used on the NHS for people with ...

Jefferies analyst Peter Welford maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of £114.00.

CNN anchor Jim Acosta cut short an interview with Corey Lewandowski after he repeatedly mispronounced Vice President Kamala Harris’ name despite being corrected. The discussion grew heated over ...

Donald Trump’s campaign reported raising over $160 million in September as it gears up for the final five weeks of the presidential election. Trump’s official campaign, joint fundraising ...